PolyPid Price to Sales Ratio 2019-2025 | PYPD

Historical PS ratio values for PolyPid (PYPD) over the last 10 years. The current P/S ratio for PolyPid as of February 09, 2026 is .

PolyPid P/S Ratio Historical Data
Date	Stock Price	TTM Sales per Share	Price to Sales Ratio
2026-02-09	4.58		0.00
2025-09-30	3.34	0	0.00
2025-06-30	3.53	0	0.00
2025-03-31	2.71	0	0.00
2024-12-31	3.04	0	0.00
2024-09-30	3.44	0	0.00
2024-06-30	4.30	0	0.00
2024-03-31	4.60	0	0.00
2023-12-31	3.80	0	0.00
2023-09-30	4.51	0	0.00
2023-06-30	10.95	0	0.00
2023-03-31	13.80	0	0.00
2022-12-31	20.93	0	0.00
2022-09-30	35.10	0	0.00
2022-06-30	139.20	0	0.00
2022-03-31	163.80	0	0.00
2021-12-31	172.20	0	0.00
2021-09-30	233.40	0	0.00
2021-06-30	271.65	0	0.00
2021-03-31	274.80	0	0.00

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$0.073B	$0.000B
PolyPid Ltd. is a pharmaceutical company. It discovers, develops and commercializes antibiotic drugs for the prevention of surgical infections. The company's product candidate includes D-PLEX100, BONYPID-1000 and BONYPID-500 which are in clinical stage. PolyPid Ltd. is based in Petach Tikva, Israel.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$96.855B	33.83
Takeda Pharmaceutical (TAK)	Japan	$56.416B	11.08
Zoetis (ZTS)	United States	$56.100B	20.08
BeOne Medicines - (ONC)	Switzerland	$38.256B	202.82
Sandoz Group AG (SDZNY)	Switzerland	$36.247B	0.00
Daiichi Sankyo, - (DSNKY)	Japan	$36.030B	17.94
United Therapeutics (UTHR)	United States	$20.371B	17.93
Shionogi (SGIOY)	Japan	$19.209B	14.85
Merck (MKKGY)	Germany	$19.083B	11.77
Neurocrine Biosciences (NBIX)	United States	$13.915B	33.39
Ionis Pharmaceuticals (IONS)	United States	$13.734B	0.00
IPSEN (IPSEY)	France	$13.565B	0.00
Orion OYJ (ORINY)	Finland	$11.953B	34.15
Summit Therapeutics (SMMT)	United States	$11.544B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$11.089B	0.00
Eisai (ESAIY)		$8.172B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$7.149B	17.10
Stevanato Group S.p.A (STVN)	Italy	$4.876B	27.29
Crinetics Pharmaceuticals (CRNX)	United States	$4.701B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.591B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.565B	21.67
Corcept Therapeutics (CORT)	United States	$4.345B	46.94
Indivior Pharmaceuticals (INDV)	United States	$4.233B	17.28
NewAmsterdam Pharma (NAMS)	Netherlands	$3.969B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$3.163B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$3.005B	9.59
Hypermarcas (HYPMY)	Brazil	$2.806B	19.26
Dyne Therapeutics (DYN)	United States	$2.427B	0.00
Soleno Therapeutics (SLNO)	United States	$2.196B	0.00
Guardian Pharmacy Services (GRDN)	United States	$2.159B	41.57
Avadel Pharmaceuticals (AVDL)	Ireland	$2.111B	0.00
Ocular Therapeutix (OCUL)	United States	$2.053B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$1.916B	22.70
Ardelyx (ARDX)	United States	$1.781B	0.00
Harrow (HROW)	United States	$1.758B	107.86
Definium Therapeutics (DFTX)	United States	$1.709B	0.00
Enliven Therapeutics (ELVN)	United States	$1.666B	0.00
Oruka Therapeutics (ORKA)	United States	$1.610B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.562B	0.00
Relay Therapeutics (RLAY)	United States	$1.499B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.463B	7.24
BioCryst Pharmaceuticals (BCRX)	United States	$1.328B	78.75
Evotec AG (EVO)	Germany	$1.307B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.155B	0.00
Savara (SVRA)	United States	$1.064B	0.00
Cronos Group (CRON)	Canada	$0.996B	0.00
Theravance Biopharma (TBPH)	United States	$0.988B	41.49
ARS Pharmaceuticals (SPRY)	United States	$0.968B	0.00
Aktis Oncology (AKTS)	United States	$0.962B	0.00
Xencor (XNCR)	United States	$0.852B	0.00
Esperion Therapeutics (ESPR)	United States	$0.794B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.787B	18.61
Nektar Therapeutics (NKTR)	United States	$0.754B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.747B	0.00
Bioventus (BVS)	United States	$0.705B	14.44
Rigel Pharmaceuticals (RIGL)	United States	$0.625B	5.58
ProKidney (PROK)	United States	$0.599B	0.00
Altimmune (ALT)	United States	$0.529B	0.00
Lexeo Therapeutics (LXEO)	United States	$0.526B	0.00
4D Molecular Therapeutics (FDMT)	United States	$0.519B	0.00
Lyell Immunopharma (LYEL)	United States	$0.494B	0.00
Organogenesis (ORGO)	United States	$0.486B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.486B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.482B	0.00
Aquestive Therapeutics (AQST)	United States	$0.481B	0.00
Siga Technologies (SIGA)	United States	$0.468B	6.40
Nature's Sunshine Products (NATR)	United States	$0.450B	26.78
Aclaris Therapeutics (ACRS)	United States	$0.400B	0.00
Akebia Therapeutics (AKBA)	United States	$0.398B	0.00
USANA Health Sciences (USNA)	United States	$0.388B	10.82
Protara Therapeutics (TARA)	United States	$0.335B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.335B	0.00
Cybin (HELP)	Canada	$0.315B	0.00
Relmada Therapeutics (RLMD)	United States	$0.308B	0.00
Larimar Therapeutics (LRMR)	United States	$0.281B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.273B	0.00
Journey Medical (DERM)	United States	$0.267B	0.00
Avalo Therapeutics (AVTX)	United States	$0.259B	0.00
OmniAb (OABI)	United States	$0.258B	0.00
Minerva Neurosciences (NERV)	United States	$0.245B	0.00
Profound Medical (PROF)	Canada	$0.236B	0.00
Heron Therapeutics (HRTX)	United States	$0.235B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.231B	0.00
MediWound (MDWD)	Israel	$0.230B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.213B	0.00
Context Therapeutics (CNTX)	United States	$0.199B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.198B	0.00
Surrozen (SRZN)	United States	$0.190B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
Galectin Therapeutics (GALT)	United States	$0.175B	0.00
AleAnna (ANNA)	United States	$0.175B	0.00
Century Therapeutics (IPSC)	United States	$0.170B	0.00
VAXART, INC (VXRT)	United States	$0.146B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.142B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.139B	0.00
Prelude Therapeutics (PRLD)	United States	$0.135B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.124B	0.00
Avita Medical (RCEL)	United States	$0.124B	0.00
Korro Bio (KRRO)	United States	$0.120B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.118B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.116B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.110B	0.00
Vivani Medical (VANI)	United States	$0.101B	0.00
Cassava Sciences (SAVA)	United States	$0.099B	0.00
Incannex Healthcare (IXHL)	Australia	$0.096B	0.00
Champions Oncology (CSBR)	United States	$0.091B	38.53
Pyxis Oncology (PYXS)	United States	$0.085B	0.00
Assertio Holdings (ASRT)	United States	$0.077B	0.00
HST Global (HSTC)	United States	$0.069B	0.00
Gain Therapeutics (GANX)	United States	$0.069B	0.00
Rafael Holdings (RFL)	United States	$0.064B	0.00
Dominari Holdings (DOMH)	United States	$0.059B	0.00
Fractyl Health (GUTS)	United States	$0.059B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.059B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.059B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.058B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.058B	48.12
BioNxt Solutions (BNXTF)	Canada	$0.056B	0.00
Nutriband (NTRB)	United States	$0.052B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.051B	0.00
Lipocine (LPCN)	United States	$0.049B	0.00
ElectroCore (ECOR)	United States	$0.043B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.040B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Liminatus Pharma (LIMN)	United States	$0.039B	0.00
Talphera (TLPH)	United States	$0.039B	0.00
Lite Strategy (LITS)	United States	$0.039B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
Plus Therapeutics (PSTV)	United States	$0.035B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.033B	0.00
SCYNEXIS (SCYX)	United States	$0.032B	0.00
TherapeuticsMD (TXMD)	United States	$0.029B	0.00
Wellgistics Health (WGRX)	United States	$0.028B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.025B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.021B	0.00
Natural Alternatives (NAII)	United States	$0.020B	0.00
Scienture Holdings (SCNX)	United States	$0.019B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Klotho Neurosciences (KLTO)	United States	$0.018B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.017B	0.00
Vivos Therapeutics (VVOS)	United States	$0.016B	0.00
Cosmos Health (COSM)	United States	$0.016B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.016B	0.00
Traws Pharma (TRAW)	United States	$0.015B	0.02
Vyome Holdings (HIND)	United States	$0.015B	0.00
Mannatech (MTEX)	United States	$0.014B	0.00
BioLineRx (BLRX)	Israel	$0.013B	0.00
Inotiv (NOTV)	United States	$0.012B	0.00
Tempest Therapeutics (TPST)	United States	$0.011B	0.00
CASI Pharmaceuticals (CASI)	China	$0.011B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.010B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.010B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.010B	0.00
Ainos (AIMD)	United States	$0.009B	0.00
BioVie (BIVI)	United States	$0.009B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.009B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.008B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Nuvilex (PMCB)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.007B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.006B	0.00
Mangoceuticals (MGRX)	United States	$0.006B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.006B	0.00
Redhill Biopharma (RDHL)	Israel	$0.005B	0.00
Aptorum Group (APM)	United Kingdom	$0.005B	0.00
Heatwurx (PCSA)	United States	$0.005B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
Xenetic Biosciences (XBIO)	United States	$0.005B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.004B	0.00
Indaptus Therapeutics (INDP)	United States	$0.004B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.003B	0.00
Lyra Therapeutics (LYRA)	United States	$0.003B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.003B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.003B	0.00
Jaguar Animal Health (JAGX)	United States	$0.002B	0.00
SciSparc (SPRC)	Israel	$0.002B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.002B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
Clearmind Medicine (CMND)	Canada	$0.002B	0.00
PainReform (PRFX)	Israel	$0.001B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
Grifols, S.A (GRFS)	Spain	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00